José Oberholzer
Gründer bei SIGILON THERAPEUTICS, INC.
Profil
José Oberholzer is the founder of Sigilon Therapeutics, Inc. He is currently the Director at Charles O Strickler Transplant Center since 2017.
Previously, he worked as a Professor at the University of Illinois and as the Head-Islet Transplant Program at the University of Geneva from 1998 to 2002.
Dr. Oberholzer has a graduate degree from Harvard University and an undergraduate degree from the University of Zurich Medical School.
Aktive Positionen von José Oberholzer
| Unternehmen | Position | Beginn |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Gründer | 14.05.2015 |
| Charles O Strickler Transplant Center | Direktor/Vorstandsmitglied | 01.03.2017 |
Celltrans, Inc.
 Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Gründer | - |
Ehemalige bekannte Positionen von José Oberholzer
| Unternehmen | Position | Ende |
|---|---|---|
| University of Geneva | Corporate Officer/Principal | 01.01.2002 |
| University of Illinois | Corporate Officer/Principal | - |
Ausbildung von José Oberholzer
| University of Zurich Medical School | Undergraduate Degree |
| Harvard University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Charles O Strickler Transplant Center | |
Celltrans, Inc.
Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Commercial Services |
